Humana (HUM)
237.96
+10.49 (4.61%)
NYSE · Last Trade: May 18th, 11:20 AM EDT
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 18, 2025
A team of experienced mental health professionals has launched Tulsa Metro Psychiatry (918-982-6524), a full-service practice offering diagnostic evaluations, medication management, and counseling services for patients across all age groups.
Via Press Release Distribution Service · May 15, 2025
Empire Psychiatry, a fast-rising name in the world of mental wellness, is proud to announce its launch as New York’s go-to destination for thoughtful, personalized psychiatric care. With a commitment to making mental health services more accessible, human-centered, and stigma-free, Empire Psychiatry is already making waves among patients and practitioners alike.
Via GetFeatured · May 14, 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 13, 2025
CenterWell Specialty Pharmacy has once again received the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category, its seventh such win in the past eight years. The award recognizes best-in-class customer satisfaction and commitment to patient care by a specialty pharmacy.
By Humana Inc. · Via Business Wire · May 13, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net earnings per share (EPS) for the quarter ended March 31, 2025 (1Q25) versus the quarter ended March 31, 2024 (1Q24) as noted in the tables below.
By Humana Inc. · Via Business Wire · April 30, 2025
Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 25, 2025 to stockholders of record as of the close of business on June 27, 2025.
By Humana Inc. · Via Business Wire · April 17, 2025
The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, Strengthening Science and Community Impact Through Equitable Research Practices. The report examines innovative research methods adopted by the Foundation’s partners to promote health equity in public health research through community-engaged research practices.
By Humana Inc. · Via Business Wire · April 16, 2025
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2024 Impact Report, showcasing the company’s dedication to improving health outcomes and supporting communities across the nation. The report underscores Humana's efforts to improve member outcomes, advance environmental sustainability, and foster a culture of belonging and well-being among its employees, while contributing to a more effective and equitable healthcare system.
By Humana Inc. · Via Business Wire · April 9, 2025
Humana Inc. (NYSE: HUM) will release financial results for the first quarter 2025 (1Q25) and host a live question-and-answer session on Wednesday, April 30, 2025. Additionally, the company will host an Investor Conference on Monday, June 16, 2025.
By Humana Inc. · Via Business Wire · April 3, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behalf of long-term stockholders following a class action complaint that was filed against Humana on June 3, 2024 with a Class Period from July 27, 2022, to January 24, 2024. Our investigation concerns whether the board of directors of Humana have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · March 31, 2025
CenterWell Senior Primary Care® is celebrating the grand opening of its new center located next to the Walmart in Gladstone, Missouri, March 26, from 10 a.m. to 1 p.m. This is the first grand opening event of the 23 centers at Walmart locations across four states scheduled to open by the middle of this year.
By Humana Inc. · Via Business Wire · March 20, 2025

Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company’s 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount, and $500 million of the company’s 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the “Senior Notes Offerings”).
By Humana Inc. · Via Business Wire · March 5, 2025

AM Best has assigned a Long-Term Issue Credit Rating of “bbb” (Good) to the $750 million, 5.5% senior unsecured notes, due 2035, and the $500 million, 6.0% senior unsecured notes, due 2055, issued by Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. The outlook assigned to these Credit Ratings (ratings) is stable. Humana’s Long-Term Issuer Credit Rating of “bbb” (Good), its Long-Term IRs and the ratings of its insurance subsidiaries are unchanged.
By AM Best · Via Business Wire · March 5, 2025

Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company’s 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount and $500 million of the company’s 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the “Senior Notes Offerings”). The Senior Notes Offerings are expected to close on March 5, 2025, subject to the satisfaction of customary closing conditions.
By Humana Inc. · Via Business Wire · March 3, 2025

Humana Inc. (NYSE: HUM), a leading health and well-being company, today introduced a new value-based care agreement with Thyme Care to provide comprehensive cancer care support for eligible Humana Medicare Advantage members. Value-based care is a holistic, patient-centered model designed to improve patient health outcomes and quality of life while helping to make healthcare more affordable and accessible.
By Humana Inc. · Via Business Wire · February 26, 2025

The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by destructive flooding in Eastern Kentucky. Following the flooding, some areas were also hit by winter snowstorm activity.
By Humana Inc. · Via Business Wire · February 24, 2025

Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25, 2025 to stockholders of record as of the close of business on March 28, 2025.
By Humana Inc. · Via Business Wire · February 20, 2025

Leading senior-focused primary care provider CenterWell Senior Primary Care® intends to continue expanding in 2025, with plans to open centers in new metro areas, including Augusta and Savannah, Georgia; the Triad Region (Burlington, Greensboro and Winston Salem) in North Carolina; and Wichita, Kansas.
By Humana Inc. · Via Business Wire · February 19, 2025

Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare Advantage members in Alabama, Louisiana, Mississippi, Tennessee, and now Georgia with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) will have access to Monogram’s evidence-based nephrology and multispecialty value-based care in the comfort of their homes.
By Humana Inc. · Via Business Wire · February 13, 2025

Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share for the quarter ended December 31, 2024 (4Q24) versus the quarter ended December 31, 2023 (4Q23) and for the year ended December 31, 2024 (FY 2024) versus the year ended December 31, 2023 (FY 2023) as noted in the tables below.
By Humana Inc. · Via Business Wire · February 11, 2025

Value-based care results in patients spending more time with their primary care clinician, less time in the hospital, and more frequent preventive care, based on research released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its annual Value-Based Care Report.
By Humana Inc. · Via Business Wire · February 5, 2025

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM).
By Kahn Swick & Foti, LLC · Via Business Wire · January 10, 2025